Edition:
United States

Biotechnology & Medical Research

Page 1

Ablynx to receive 15 million euros milestone payment

Monday, 22 May 2017 01:00am EDT

May 22 (Reuters) - ABLYNX NV ::NOVEL NANOBODY TO START CLINICAL DEVELOPMENT IN OSTEOARTHRITIS - ABLYNX TO RECEIVE €15 MILLION MILESTONE PAYMENT.ABLYNX ANNOUNCED THAT IT HAS COMPLETED PREPARATION OF A PRE-CLINICAL PACKAGE FOR A NOVEL NANOBODY® (ALX-1141) IN OSTEOARTHRITIS.AS PART OF ONGOING COLLABORATION BETWEEN ABLYNX AND MERCK KGAA <<>>, MERCK HAS ACCEPTED PRE-CLINICAL PACKAGE AND THIS HAS TRIGGERED A EUR 15 MILLION MILESTONE PAYMENT TO ABLYNX.MERCK IS NOW RESPONSIBLE FOR FURTHER CLINICAL DEVELOPMENT OF MOLECULE.

Tissue Regenix confirms discussions with Cellright regarding possible acquisition

Friday, 19 May 2017 06:35am EDT

May 19 (Reuters) - Tissue Regenix Group Plc ::Confirms that it is in discussions with Cellright regarding possible acquisition of Cellright by Tissue Regenix.

Soiken Holdings to buy 58.6 pct stake in NRL Pharma

Friday, 19 May 2017 02:16am EDT

May 19 (Reuters) - Soiken Holdings Inc <2385.T> ::* Says it plans to buy 58.6 percent stake in NRL Pharma Inc for totaling 528 million yen, on June 27.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary